Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:26344103  

Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis.

Lawrence R Gray | Mst Rasheda Sultana | Adam J Rauckhorst | Lalita Oonthonpan | Sean C Tompkins | Arpit Sharma | Xiaorong Fu | Ren Miao | Alvin D Pewa | Kathryn S Brown | Erin E Lane | Ashley Dohlman | Diana Zepeda-Orozco | Jianxin Xie | Jared Rutter | Andrew W Norris | James E Cox | Shawn C Burgess | Matthew J Potthoff | Eric B Taylor
Cell metabolism | 2015

Gluconeogenesis is critical for maintenance of euglycemia during fasting. Elevated gluconeogenesis during type 2 diabetes (T2D) contributes to chronic hyperglycemia. Pyruvate is a major gluconeogenic substrate and requires import into the mitochondrial matrix for channeling into gluconeogenesis. Here, we demonstrate that the mitochondrial pyruvate carrier (MPC) comprising the Mpc1 and Mpc2 proteins is required for efficient regulation of hepatic gluconeogenesis. Liver-specific deletion of Mpc1 abolished hepatic MPC activity and markedly decreased pyruvate-driven gluconeogenesis and TCA cycle flux. Loss of MPC activity induced adaptive utilization of glutamine and increased urea cycle activity. Diet-induced obesity increased hepatic MPC expression and activity. Constitutive Mpc1 deletion attenuated the development of hyperglycemia induced by a high-fat diet. Acute, virally mediated Mpc1 deletion after diet-induced obesity decreased hyperglycemia and improved glucose tolerance. We conclude that the MPC is required for efficient regulation of gluconeogenesis and that the MPC contributes to the elevated gluconeogenesis and hyperglycemia in T2D.

Pubmed ID: 26344103

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAMS NIH HHS, United States
    Id: R00 AR059190
  • Agency: NIDDK NIH HHS, United States
    Id: R24 DK096518
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK104998
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK078184
  • Agency: NHLBI NIH HHS, United States
    Id: T32 HL007638
  • Agency: NHLBI NIH HHS, United States
    Id: T32 HL007121
  • Agency: NCI NIH HHS, United States
    Id: P30 CA086862
  • Agency: NIDDK NIH HHS, United States
    Id: P01 DK058398
  • Agency: NCI NIH HHS, United States
    Id: P30CA086862
  • Agency: NCI NIH HHS, United States
    Id: T32 CA078586
  • Agency: NIDDK NIH HHS, United States
    Id: F32 DK101183
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007337
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM094232
  • Agency: NIGMS NIH HHS, United States
    Id: GM007337

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Microsoft Excel (tool)

RRID:SCR_016137

Software application with data analysis tools and spreadsheet templates to track and visualize data. It is used to manage and process data.

View all literature mentions

International Mouse Phenotyping Consortium (IMPC) (tool)

RRID:SCR_006158

Center that produces knockout mice and carries out high-throughput phenotyping of each line in order to determine function of every gene in mouse genome. These mice will be preserved in repositories and made available to scientific community representing valuable resource for basic scientific research as well as generating new models for human diseases.

View all literature mentions